Thérapies de Conversion

Correction: Conversion therapy with TACE, TKIs, and ICIs for unresectable BCLC stage B and C hepatocellular carcinoma.

Front Immunol . 2025;16 :1647890

Résumé

[This corrects the article DOI: 10.3389/fimmu.2025.1451965.].

Tous les articles